Inflixamab and pericardial effusion Patient Reports February 09, 2012

Inflixamab Side Effects Report #5796760-8
Inflixamab side effect was reported by a Pharmacist from UNITED STATES on June 30, 2008. Female patient, child 11 years of age, weighting 96.34 lb, was diagnosed with crohn's disease  and was treated with Inflixamab. After drug was administered, patient experienced the following side effects: lupus-like syndrome, pericardial effusion, pleural effusion. Inflixamab dosage: 200 MG EVERY 6 WEEKS IV. Patient was hospitalized and became disabled. Patient recovered.